CVE-2026-11372 — IBM TRIRIGA Cross-Site Scripting Vulnerability
IBM TRIRIGA Application Platform 5.0.2 through 5.0.3 is vulnerable to cross-site scripting. This vulnerability allows an authenticated user to embed arbitrary JavaScript code in the Web UI thus altering the intended functionality potentially leading to credentials disclosure within a trusted session.
Who exploits it and how urgent it is
A 0–100 score combining confirmed exploitation, ransomware and APT use, public exploits, EPSS and severity.
How the score was calculated
- EPSS 0.2% (30-day exploitation probability)+2
- Technical severity (medium)+3
The score orders the patch queue; it does not replace your asset context (internet exposure, criticality, compensating controls).
Triage
Is it exploited, how likely is exploitation, what does it touch, and how severe do the sources call it.
CISA SSVC assessment CISA
Three decision points CISA publishes for the CVEs it assesses (SSVC 2.0.3). A stakeholder decision, not a severity score.
Remediation
Fixes and mitigations documented by the sources — linked to the original advisory.
No fix documented by the sources we poll. That does not mean none exists: check the vendor advisory.
First 24 hours
Ordered from the record’s own fields — exposure first, because you cannot patch what you have not found. A rule-generated starting point.
- Identify exposed assets running the affected vendor/product/version combinations (Ibm Tririga Application Platform).
- No fix documented in the sources: reduce exposure and monitor the vendor advisory.
- Exploitation requires user interaction: tighten email/web filtering and warn affected users.
- Search available logs for exploit probes matching the vulnerability class (cross-site scripting), errors and authentication anomalies.
Affected scope
Vendor, product and versions as the sources word them.
| Vendor | Product | Versions | Status | Source |
|---|---|---|---|---|
| Ibm | Tririga Application Platform | version 5.0.2version 5.0.3 | Vulnerable | NIST National Vulnerability Database |
| Ibm | Tririga Application Platform | ≥ 5.0.2 and ≤ 5.0.3 | Vulnerable | CVE Program (cve.org) e CISA ADP |
Attack characteristics
The CVSS vector, decoded. It describes the attack, not your exposure to it.
Every base score collected
Sources score independently and may disagree; each row says who scored it and under which version.
| Score | Version | Severity | Expl. | Impact | Scored by |
|---|---|---|---|---|---|
| 5.4 | CVSS 3.1 | Medium | 2.8 | 2.5 | psirt@us.ibm.com via NIST National Vulnerability Database |
| 5.4 | CVSS 3.1 | Medium | 2.3 | 2.7 | nvd@nist.gov via NIST National Vulnerability Database |
| 5.4 | CVSS 3.1 | Medium | — | — | ibm via CVE Program (cve.org) e CISA ADP |
CVSS:3.1/AV:N/AC:L/PR:L/UI:R/S:C/C:L/I:L/A:N (score shown at the top: nvd@nist.gov) Weakness MITRE
Weakness class according to MITRE’s CWE catalog.
EPSS over time FIRST
Oct 13, 2026 → Oct 14, 2026 · 2 reading(s) · max 0.23%
Detection
Read off the CVSS vector and the weakness class. Starting points, not tested rules.
- Prioritize edge telemetry for the network-reachable component (proxy, WAF, IDS/IPS).
- Monitor CSP violation reports and script payloads in reflected parameters.
Timeline
What happened to this CVE, newest first.
- 2026
- Affected products added · ibm/tririga application platform
- SSVC assessment updated
- Record published
- CVSS changed · 5.4
- Source status changed · → Analyzed
- Record created in this database
- CVE published
Source activity
Repeated readings are counted rather than listed.
- 1× Official description updated · Oct 13, 2026 – Oct 13, 2026
References
1 on the record
Elsewhere on this site
Related CVEs (same products)
- High CVE-2026-93891 Security Vulnerability identified in IBM TRIRIGA - XXE 2d
- High CVE-2026-93892 Security Vulnerability identified in IBM TRIRIGA - Information Disclosure in Admin Console 2d
- High CVE-2026-102627 Security Vulnerability identified in IBM TRIRIGA - Zip Slip 2d
Not in any source we poll
Listed rather than left blank: an empty field and an unmeasured one look identical on screen, and only one is a reason to look elsewhere.
- No fixed version, patch or mitigation documented.
- No confirmed IOCs, IP addresses, domains, file hashes, or malware artifacts supplied.
- No organization-specific asset inventory, compensating-control status, or patch deployment evidence supplied.
- No exploit packet captures, log samples, or incident case IDs supplied.
Answered from this record
Text assembled only from the fields above — no additional claims.
What should defenders know first?
CVE-2026-11372 is "IBM TRIRIGA Cross-Site Scripting Vulnerability", rated Medium. It affects Tririga Application Platform (Ibm); versions are in the scope table. It is not in CISA KEV, which does not rule out exploitation. CVSS 5.4 describes technical severity. EPSS 0.23% estimates the probability of exploitation in 30 days; neither replaces your asset context. First verify whether exposed or business-critical assets run the affected versions, apply vendor fixes or mitigations, and preserve logs for review.
Comments
Moderated technical discussion. Read the community guidelines.
No comments yet.
Sign in or create an account to comment and suggest corrections.